These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 34479168)
21. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Alagona G; Bella R; Ferri R; Carnemolla A; Pappalardo A; Costanzo E; Pennisi G Neurosci Lett; 2001 Nov; 314(1-2):57-60. PubMed ID: 11698146 [TBL] [Abstract][Full Text] [Related]
22. Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer's disease. Ulbl J; Rakusa M Acta Neurol Belg; 2022 Jun; 122(3):695-702. PubMed ID: 34424494 [TBL] [Abstract][Full Text] [Related]
24. Relationship between excitability, plasticity and thickness of the motor cortex in older adults. List J; Kübke JC; Lindenberg R; Külzow N; Kerti L; Witte V; Flöel A Neuroimage; 2013 Dec; 83():809-16. PubMed ID: 23876242 [TBL] [Abstract][Full Text] [Related]
25. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia. Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904 [TBL] [Abstract][Full Text] [Related]
26. Impaired Cognitive Function is Associated with Motor Function and Activities of Daily Living in Mild to Moderate Alzheimer's Dementia. Lee G Curr Alzheimer Res; 2020; 17(7):680-686. PubMed ID: 32811414 [TBL] [Abstract][Full Text] [Related]
27. Intra- and inter-cortical motor excitability in Alzheimer's disease. Hoeppner J; Wegrzyn M; Thome J; Bauer A; Oltmann I; Buchmann J; Teipel S J Neural Transm (Vienna); 2012 May; 119(5):605-12. PubMed ID: 22080177 [TBL] [Abstract][Full Text] [Related]
28. Dorsolateral prefrontal cortex excitability abnormalities in Alzheimer's Dementia: Findings from transcranial magnetic stimulation and electroencephalography study. Joseph S; Knezevic D; Zomorrodi R; Blumberger DM; Daskalakis ZJ; Mulsant BH; Pollock BG; Voineskos A; Wang W; Rajji TK; Kumar S Int J Psychophysiol; 2021 Nov; 169():55-62. PubMed ID: 34499960 [TBL] [Abstract][Full Text] [Related]
29. Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease. Nardone R; Tezzon F; Höller Y; Golaszewski S; Trinka E; Brigo F Acta Neurol Scand; 2014 Jun; 129(6):351-66. PubMed ID: 24506061 [TBL] [Abstract][Full Text] [Related]
30. Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation. Trebbastoni A; Gilio F; D'Antonio F; Cambieri C; Ceccanti M; de Lena C; Inghilleri M Clin Neurophysiol; 2012 May; 123(5):902-9. PubMed ID: 21996001 [TBL] [Abstract][Full Text] [Related]
32. Cortical plasticity is correlated with cognitive improvement in Alzheimer's disease patients after rTMS treatment. Li X; Qi G; Yu C; Lian G; Zheng H; Wu S; Yuan TF; Zhou D Brain Stimul; 2021; 14(3):503-510. PubMed ID: 33581283 [TBL] [Abstract][Full Text] [Related]
33. Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease. Takahashi M; Oda Y; Okubo T; Shirayama Y J Neural Transm (Vienna); 2017 Sep; 124(9):1109-1121. PubMed ID: 28509077 [TBL] [Abstract][Full Text] [Related]
34. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation follow-up study. Ferreri F; Pasqualetti P; Määttä S; Ponzo D; Guerra A; Bressi F; Chiovenda P; Del Duca M; Giambattistelli F; Ursini F; Tombini M; Vernieri F; Rossini PM Neurosci Lett; 2011 Apr; 492(2):94-8. PubMed ID: 21281700 [TBL] [Abstract][Full Text] [Related]
35. The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI. Skinner J; Carvalho JO; Potter GG; Thames A; Zelinski E; Crane PK; Gibbons LE; Brain Imaging Behav; 2012 Dec; 6(4):489-501. PubMed ID: 22614326 [TBL] [Abstract][Full Text] [Related]
36. Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability. Pennisi G; Ferri R; Lanza G; Cantone M; Pennisi M; Puglisi V; Malaguarnera G; Bella R J Neural Transm (Vienna); 2011 Apr; 118(4):587-98. PubMed ID: 21207079 [TBL] [Abstract][Full Text] [Related]
37. Altered Cortical Synaptic Plasticity in Response to 5-Hz Repetitive Transcranial Magnetic Stimulation as a New Electrophysiological Finding in Amnestic Mild Cognitive Impairment Converting to Alzheimer's Disease: Results from a 4-year Prospective Cohort Study. Trebbastoni A; Pichiorri F; D'Antonio F; Campanelli A; Onesti E; Ceccanti M; de Lena C; Inghilleri M Front Aging Neurosci; 2015; 7():253. PubMed ID: 26793103 [TBL] [Abstract][Full Text] [Related]
38. D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment. Lin CH; Yang HT; Lane HY Pharmacol Biochem Behav; 2019 Oct; 185():172760. PubMed ID: 31422081 [TBL] [Abstract][Full Text] [Related]
39. Gender impact on transcranial magnetic stimulation-based cortical excitability and cognition relationship in healthy individuals. Akilan K; Kumar S; Zomorrodi R; Blumberger DM; Daskalakis ZJ; Rajji TK Neuroreport; 2020 Mar; 31(4):287-292. PubMed ID: 31895750 [TBL] [Abstract][Full Text] [Related]
40. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM; J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]